CSG's €18 Billion Backlog Meets a Cash Drain and a Thinner Margin

CSG spent Wednesday answering a question its order book cannot settle on its own: can a defence group sitting on €18 billion of contracted work turn those commitments into profit and cash fast enough to justify the market's patience? The shares fell 20% after the company cut its 2026 operating margin outlook and reported a weak third quarter, with a second report putting the decline at 21%.

The trigger was a guidance revision. CSG now expects an operating EBIT margin of around 21% for 2026, down from the 24–25% it had previously targeted. Management pointed to cheaper ammunition sales and a larger revenue contribution from the lower-margin Land Systems division, whose margins are still being built out. The revenue target, by contrast, was left untouched at €7.4–7.6 billion.

Where the margin went

Two forces are squeezing profitability at once. Demand is rotating away from standard-range ammunition toward longer-range products, and CSG cleared out inventories of the standard rounds at lower market prices. CFO Zdenek Jurak said prices for standard-range ammunition initially fell by roughly 20%. The company also accelerated sales of older stock at reduced prices, a mix shift that weighs on earnings quality even where volumes hold up.

Jurak added that the demand share for standard-range ammunition has come in below original expectations, adding pressure on the product side. The planned answer is full in-house production of long-range ammunition by the end of 2027 — a credible response, provided the build-out stays on schedule and matches where demand has actually moved.

The quarter behind the warning

Revenue for the third quarter of 2026 came in at €1.51 billion. Operating profit fell 21% to €317 million. On top of that, roughly €300 million of deliveries slipped from the third quarter into the fourth, a shift the company flagged particularly in Land Systems. The full-year revenue guidance now leans heavily on those orders arriving before the year closes. If they do, part of the weakness is a matter of timing rather than lost business — but management has to prove that with delivery, not with explanation.

An order book that outruns the cash register

The backlog reached €18 billion at the end of September, up from €15 billion in December 2025, according to media reports. Against that, cash flow before tax for the first nine months of 2026 stood at minus €200 million. That contrast is the heart of the investment case: the pipeline offers visibility, but its value to shareholders only grows as it converts into profitable shipments and better cash generation.

Working capital is the second pressure point. CSG now expects net working capital for 2026 below 35% of revenue, having previously aimed for under 20%. The loosened target raises the bar for financing day-to-day operations.

Some relief comes from the refinancing of €3.1 billion, which trims financing costs by 125–150 basis points and extends maturities to six years. That buys room to manoeuvre — useful only if it is spent on more reliable execution.

The analyst note that predates the cut

Jefferies reaffirmed its buy rating on CSG and its €25.00 price target on Monday. That call was published before Wednesday's margin reduction, and the stock has since moved well away from it.

For investors, the test now sits in three places: whether the delayed deliveries land in the fourth quarter of 2026, whether the margin finds a floor, and whether cash flow improves. Operational progress, not the sheer size of the backlog, is the measure that matters from here.